Biotech · Private company
Treadwell Therapeutics, Inc
Track this companyFree. Adds Treadwell Therapeutics, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AzacitidinePhase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- CFI-400945Phase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- CFI-402257Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CFI-402411Phase 2 · Advanced Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Advanced Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 27, 2022ClinicalTrials.gov NCT05251714 · fetched Nov 12, 2026
- A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMMLPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Apr 16, 2021ClinicalTrials.gov NCT04730258 · fetched Nov 12, 2026
- Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid MalignanciesPHASE1_PHASE2 · UNKNOWN · started Aug 31, 2020ClinicalTrials.gov NCT04521413 · fetched Nov 12, 2026